/MASS
MASS Stock - 908 Devices Inc.
Healthcare|Medical - DevicesNASDAQ
$5.84+7.55%
+$0.41 (+7.55%) • Dec 19
62
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.HOLD
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.28
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).70
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.100
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+10.0%upside
Target: $6.42
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for MASS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$5.78 – $5.90
TARGET (TP)$6.72
STOP LOSS$5.37
RISK/REWARD1:1.9
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.46
52W High$9.34
52W Low$1.81
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $59.63M | $50.23M | $46.85M | $42.21M | $26.89M |
| Gross Profit | $29.93M | $25.32M | $26.02M | $23.23M | $14.92M |
| Gross Margin | 50.2% | 50.4% | 55.5% | 55.0% | 55.5% |
| Operating Income | $-76,718,000 | $-42,758,000 | $-35,382,000 | $-22,069,000 | $-5,815,000 |
| Net Income | $-72,206,000 | $-36,399,000 | $-33,563,000 | $-22,169,000 | $-12,819,000 |
| Net Margin | -121.1% | -72.5% | -71.6% | -52.5% | -47.7% |
| EPS | $-2.12 | $-1.13 | $-1.07 | $-0.79 | $-2.35 |
Company Overview
908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
1
100%
Hold / Neutral
0%
Sell / Underperform
0%
Analyst Consensus🟢 Bullish
1 Bullish0 Neutral/Bearish
Price Targets
$10
Average Target
↑ 71.2% Upside
Now
$4
Low
$10
Average
$14
High
Based on 3 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| August 5th 2025 | Leerink Partners | Upgrade | Outperform | $12 |
| November 13th 2024 | Leerink Partners | Downgrade | Market Perform | $4← $12 |
| February 7th 2023 | Stephens | Initiation | Overweight | $14 |
Earnings History & Surprises
MASSBeat Rate
56%
Last 18 quarters
Avg Surprise
+0.9%
EPS vs Estimate
Beats / Misses
10/6
2 met exactly
Latest EPS
$-0.15
Q4 2025
EPS Surprise History
Q1 24
+14.8%
$-0.23vs$-0.27
Q2 24
+10.8%
$-0.33vs$-0.37
Q3 24
+5.9%
$-0.32vs$-0.34
Q4 24
+20.7%
$-0.23vs$-0.29
Q1 25
+8.6%
$-0.32vs$-0.35
Q2 25
+18.5%
$-0.22vs$-0.27
Q3 25
-12.5%
$-0.18vs$-0.16
Q4 25
-30.4%
$-0.15vs$-0.12
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 11, 2026 | — | — | — | — |
Q1 2026 | Mar 3, 2026 | $-0.06 | — | — | — |
Q4 2025 | Nov 10, 2025 | $-0.12 | $-0.15 | -30.4% | ✗ MISS |
Q3 2025 | Aug 5, 2025 | $-0.16 | $-0.18 | -12.5% | ✗ MISS |
Q2 2025 | May 13, 2025 | $-0.27 | $-0.22 | +18.5% | ✓ BEAT |
Q1 2025 | Mar 4, 2025 | $-0.35 | $-0.32 | +8.6% | ✓ BEAT |
Q4 2024 | Nov 12, 2024 | $-0.29 | $-0.23 | +20.7% | ✓ BEAT |
Q3 2024 | Aug 6, 2024 | $-0.34 | $-0.32 | +5.9% | ✓ BEAT |
Q2 2024 | Apr 30, 2024 | $-0.37 | $-0.33 | +10.8% | ✓ BEAT |
Q1 2024 | Mar 5, 2024 | $-0.27 | $-0.23 | +14.8% | ✓ BEAT |
Q4 2023 | Nov 7, 2023 | $-0.30 | $-0.22 | +26.7% | ✓ BEAT |
Q3 2023 | Aug 8, 2023 | $-0.33 | $-0.29 | +12.1% | ✓ BEAT |
Q2 2023 | May 9, 2023 | $-0.35 | $-0.39 | -11.4% | ✗ MISS |
Q1 2023 | Mar 7, 2023 | $-0.22 | $-0.31 | -40.9% | ✗ MISS |
Q4 2022 | Nov 14, 2022 | $-0.22 | $-0.20 | +9.1% | ✓ BEAT |
Q3 2022 | Aug 9, 2022 | $-0.26 | $-0.26 | 0.0% | = MET |
Q2 2022 | May 10, 2022 | $-0.30 | $-0.30 | 0.0% | = MET |
Q1 2022 | Mar 7, 2022 | $-0.18 | $-0.12 | +33.3% | ✓ BEAT |
Q4 2021 | Nov 4, 2021 | $-0.15 | $-0.19 | -26.7% | ✗ MISS |
Q3 2021 | Aug 4, 2021 | $-0.22 | $-0.27 | -22.7% | ✗ MISS |
Latest News
Reported Friday, MAAS Appoints Jingkai Li As Chairman And Director As Hong Suong Nguyen Resigns From The Board
➖ NeutralBenzinga•Dec 1, 2025, 07:44 AM
908 Devices Affirms FY2025 Sales Guidance of $54.000M-$56.000M vs $55.403M Est
➖ NeutralBenzinga•Nov 10, 2025, 12:02 PM
908 Devices Q3 EPS $(0.41) Misses $(0.16) Estimate, Sales $14.005M Beat $13.578M Estimate
➖ NeutralBenzinga•Nov 10, 2025, 12:01 PM
908 Devices Sells 17 XplorIR Units to US Marine Corps for Hazardous Gas Detection
📈 PositiveBenzinga•Oct 16, 2025, 11:07 AM
Frequently Asked Questions about MASS
What is MASS's current stock price?
908 Devices Inc. (MASS) is currently trading at $5.84 per share. The stock has moved +7.55% today.
What is the analyst price target for MASS?
No analyst price targets are currently available for this stock.
What sector is 908 Devices Inc. in?
908 Devices Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is MASS's market cap?
908 Devices Inc. has a market capitalization of $0.21 billion, making it a small-cap company.
Does MASS pay dividends?
No, 908 Devices Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACRS
Aclaris Therapeutics, Inc.
$3.14
Mkt Cap: $0.3B
CAPR
Capricor Therapeutics, Inc.
$27.81
Mkt Cap: $1.3B
CERS
Cerus Corporation
$2.09
Mkt Cap: $0.4B
CVRX
CVRx, Inc.
$8.03
Mkt Cap: $0.2B
NNOX
Nano-X Imaging Ltd.
$2.99
Mkt Cap: $0.2B
NPCE
NeuroPace, Inc.
$16.59
Mkt Cap: $0.6B
QTRX
Quanterix Corporation
$6.59
Mkt Cap: $0.3B
SENS
Senseonics Holdings, Inc.
$6.15
Mkt Cap: $0.3B
SGHT
Sight Sciences, Inc.
$8.45
Mkt Cap: $0.4B
SNWV
SANUWAVE Health, Inc.
$32.25
Mkt Cap: $0.3B
Explore stocks similar to MASS for comparison